Akebia Therapeutics(DE:AX9)
€0.47+0.11 (+30.28%)
DE:AX9
Akebia Therapeutics Revenue
€0.47
At close:+0.11 (+30.28%)
Akebia Therapeutics (AX9) Revenue
2 Followers
Akebia Therapeutics Revenue
Akebia Therapeutics had a revenue of 36.90M in the quarter ending Sep 30, 2026, with -24.88%. This bring the company's revenue in the last twelve months to 197.19M, Decreased 9.98%. In the fiscal year ending Dec 31, 2025, Akebia Therapeutics had annual revenue of 236.20M with 47.46% growth.
- Revenue (ttm)
- 197.19M
- Revenue Growth
- -16.65%
- P/S Ratio
- 0.57
- Revenue/Employee
- EUR 1,217,505
- Employees
- 194
- Market Cap
- EUR 135.57M
Revenue Chart
Akebia Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 236.20M | 76.02M | 47.46% |
| Dec 31, 2024 | 160.18M | -34.44M | -17.70% |
| Dec 31, 2023 | 194.62M | -97.86M | -33.46% |
| Dec 31, 2022 | 292.48M | 80.83M | 38.19% |
| Dec 31, 2021 | 211.65M | -82.99M | -28.17% |
| Dec 31, 2020 | 294.64M | -40.36M | -12.05% |
| Dec 31, 2019 | 335.00M | 127.26M | 61.26% |
| Dec 31, 2018 | 207.74M | 29.76M | 16.72% |
| Dec 31, 2017 | 177.98M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.